Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy

NCT01128959 is registered in ClinicalTrials.gov with Lundbeck LLC as lead sponsor.

NCT NCT01128959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01128959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Lead sponsor
Lundbeck LLC
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2010
Completion date
January 31, 2013
Enrollment
108 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy